Low-Dose Spironolactone in the Treatment of Female Hirsutism

A 20-year-old female is using finasteride 5mg and spironolactone 100mg for severe hirsutism and is experiencing minor side effects like water weight loss and irregular periods. She is concerned about potential future side effects and hair regrowth on her scalp.

A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

Prolactin may contribute to hair loss, but targeting its receptor won't cure androgenetic alopecia. ABS-201 could be a useful alternative or adjuvant therapy, similar to JAK inhibitors, but not more effective than HMI-115.

The user experienced side effects from minoxidil, including hirsutism and facial changes, and switched to castor oil, which has not caused similar side effects. They continue using microneedling and dutasteride, reporting minor hair shedding but no significant hair loss.

A user experienced hair shedding after stopping and restarting topical minoxidil due to side effects like facial edema and hirsutism. They are considering alternatives like low-dose oral minoxidil, PRP, and red light therapy, while others suggest finasteride and caution against combining multiple treatments without medical advice.

Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.